These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22447196)

  • 1. Efficacy and safety of aripiprazole in child and adolescent patients.
    Kirino E
    Eur Child Adolesc Psychiatry; 2012 Jul; 21(7):361-8. PubMed ID: 22447196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
    Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aripiprazole use in children and adolescent psychiatric patients].
    Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
    Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder.
    McKeage K
    CNS Drugs; 2014 Feb; 28(2):171-83. PubMed ID: 24399490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic.
    Buckley PF
    Drugs Today (Barc); 2003 Feb; 39(2):145-51. PubMed ID: 12698209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
    Mankoski R; Stockton G; Manos G; Marler S; McQuade R; Forbes RA; Marcus R
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):572-6. PubMed ID: 24138011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
    Centorrino F; Fogarty KV; Cimbolli P; Salvatore P; Thompson TA; Sani G; Cincotta SL; Baldessarini RJ
    J Psychiatr Pract; 2005 Jul; 11(4):241-7. PubMed ID: 16041234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.
    Gupta S; Masand P
    Ann Clin Psychiatry; 2004; 16(3):155-66. PubMed ID: 15517848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
    Findling RL; Kauffman RE; Sallee FR; Carson WH; Nyilas M; Mallikaarjun S; Shoaf SE; Forbes RA; Boulton DW; Pikalov A
    J Clin Psychopharmacol; 2008 Aug; 28(4):441-6. PubMed ID: 18626272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.
    DeLeon A; Patel NC; Crismon ML
    Clin Ther; 2004 May; 26(5):649-66. PubMed ID: 15220010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Corey-Lisle PK; Aman MG
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):229-36. PubMed ID: 21663425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label study of aripiprazole in children with a bipolar disorder.
    Findling RL; McNamara NK; Youngstrom EA; Stansbrey RJ; Frazier TW; Lingler J; Otto BD; Demeter CA; Rowles BM; Calabrese JR
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):345-51. PubMed ID: 21823912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
    J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review.
    Doey T
    J Affect Disord; 2012; 138 Suppl():S15-21. PubMed ID: 22406333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
    Findling RL; Robb A; Nyilas M; Forbes RA; Jin N; Ivanova S; Marcus R; McQuade RD; Iwamoto T; Carson WH
    Am J Psychiatry; 2008 Nov; 165(11):1432-41. PubMed ID: 18765484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1157-8; author reply 1159. PubMed ID: 20381569
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole.
    Fleischhacker WW
    Expert Opin Pharmacother; 2005 Oct; 6(12):2091-101. PubMed ID: 16197361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.